American Journal of Ophthalmology
Volume 137, Issue 2 , Pages 283-286 , February 2004

Orientational contrast sensitivity and chromatic contrast thresholds in multiple sclerosis

  • Timothy L Jackson, FRCOphth

      Affiliations

    • Sussex Eye Hospital, Brighton, United Kingdom (T.J., G.O.)
    • Corresponding Author InformationInquiries to Timothy L. Jackson, FRCOphth, Department of Ophthalmology, Rayne Institute, St. Thomas' Hospital, London SE1 7EH, United Kingdom; fax: (+44) 020-7401-9062
  • ,
  • Gek L Ong, PhD

      Affiliations

    • Sussex Eye Hospital, Brighton, United Kingdom (T.J., G.O.)
    • the Biomedical Engineering Division, University of Sussex, Sussex, United Kingdom (G.O., L.R.)
  • ,
  • Lionel G Ripley, PhD

      Affiliations

    • the Biomedical Engineering Division, University of Sussex, Sussex, United Kingdom (G.O., L.R.)

,Accepted 10 August 2003.

References 

  1. Regan D, Whitlock JA, Murray TJ, Beverley KI. Orientation specific losses of contrast sensitivity in multiple sclerosis. Invest Opthalmol Vis Sci. 1980;19:324–328
  2. Kupersmith MJ, Seiple WH, Nelson JJ, Carr RE. Contrast sensitivity loss in multiple sclerosis. Invest Opthalmol Vis Sci. 1984;25:632–639
  3. Regan D, Maxner C. Orientation dependent loss of pattern sensitivity and flicker sensitivity in multiple sclerosis. Clin Vis Sci. 1986;1:1–23
  4. Tulunay-Keesey U, Brooks BR, Kukuljan R, Hoeve JN. Effect of orientation on spatiotemporal contrast sensitivity in multiple sclerosis. Vis Res. 1994;34:123–136
  5. Katz B. The dyschromatopsia of optic neuritis (a descriptive analysis of data from the optic neuritis treatment trial). Trans Am Ophthalmol Soc. 1995;93:685–708
  6. Mullen KT, Plant GT. Colour and luminance vision in human optic neuritis. Brain. 1986;109:1–13
  7. McDonald WI, Compston A, Edan G, et al.  Recommended diagnostic criteria for multiple sclerosis (guidelines from the international panel on the diagnosis of multiple sclerosis). Ann Neurol. 2001;50:121–127
  8. Kurtzke JF. Rating neurological impairment in multiple sclerosis (an expanded disability status scale (EDSS)). Neurology. 1983;33:1452
  9. Jackson TL, Ong GL, McIndoe MA, Ripley LG. Monocular chromatic contrast threshold and achromatic contrast sensitivity in children born prematurely. Am J Ophthalmol. 2003;136:710–719
  10. Apkarian P, Tijssen R, Spekreijse H, Regan D. Origin of notches in CSF (optical or neural?). Invest Opthalmol Vis Sci. 1987;28:607–612
  11. Tregear SJ, Knowles PJ, Ripley LG, de Alwis DV, Reffin JP, Casswell AG. Automated tritan discrimination sensitivity (a new clinical technique for the effective screening of severe diabetic retinopathy). Int J Psychophysiol. 1994;16:191–198
  12. Cornsweet TN. The staircase method in psychophysics. Am J Psychophys. 1962;75:485–491
  13. Köllner H. Die Storungen des Farbensinnes (Ihre klinische Bedeutung und ihre Diagnose). Berlin: Karger; 1912;
  14. Cox J. Colour vision defects acquired in disease of the eye. Br J Physiol Opt. 1960;17:17
  15. Tsukamoto M, Adachi-Usami E. Color vision in multiple sclerosis with optic neuritis. Acta Soc Ophthalmol Jpn. 1987;91:613–621
  16. Travis D, Thompson P. Spatiotemporal contrast sensitivity and colour vision in multiple sclerosis. Brain. 1989;112:283–303
  17. Harrison AC, Becker WJ, Stell WK. Colour vision abnormalities in multiple sclerosis. Can J Neurol Sci. 1987;14:279–285
  18. Fallowfield L, Krauskopf J. Selective loss of chromatic sensitivity in demyelinating disease. Invest Opthalmol Vis Sci. 1984;25:771–773
  19. Porciatti V, Sartucci F. Retinal and cortical evoked responses to chromatic contrast stimuli-specific losses in both eyes of patients with multiple sclerosis and unilateral optic neuritis. Brain. 1996;119:740
  20. Fleishman JA, Beck RW, Linares OA, Klein JW. Deficits in visual function after resolution of optic neuritis. Ophthalmology. 1987;94:1029–1035
  21. Zimmern RL, Campbell FW, Wilkinson IMS. Subtle disturbances of vision after optic neuritis elicited by studying contrast sensitivity. J Neurol Neurosurg Psychiatry. 1979;42:407–412

PII: S0002-9394(03)00970-X

doi: 10.1016/j.ajo.2003.08.032

American Journal of Ophthalmology
Volume 137, Issue 2 , Pages 283-286 , February 2004